ASCRS 2024: International data are forthcoming in corneal endothelial disease treatment
At ASCRS 2024, Aurion Biotech's Global VP Eris Jordan previews upcoming clinical data from North America and Asia
ASCRS 2024: Comparing keratometry and total keratometry values in a large dataset
Jascha Wendelstein, MD, discusses the outcomes of a study comparing K and TK measurements
ASCRS 2024: What's new in the ESCRS IOL calculator?
At ASCRS 2024, Oliver Findl, MD, provides an update on the ESCRS IOL calculator and new tools to come this year
ASCRS 2024: At Eyecelerator, a New Zealand-based startup pitches eye drops for keratoconus
Ahead of the ASCRS 2024 meeting, TheiaNova CEO Carissa Fonseca, PhD, pitched a novel keratoconus treatment
ASCRS 2024: Surgical and pharmaceutical technology updates from Bausch + Lomb
At the 2024 ASCRS meeting, Anthony Wallace details the presentations and educational programmes from Bausch + Lomb
ASCRS 2024: Ease of opening arcuate incisions created with a dual pulse femtosecond laser
At the ASCRS meeting in Boston, Dan Tran, MD, details his presentation on incision quality and clinical outcomes of femtosecond laser
ASCRS 2024: 10-year results from a real-world study shed new light on glaucoma
At ASCRS in Boston, Paul Harasymowycz, MD shared a decade's worth of data on MIGS procedures for primary open-angle glaucoma
ASCRS 2024: Ultra-low cylinder powered toric versus non-toric lenses in cataract surgery
Adam Muzychuk, MD, BSc, FRCSC, discusses his ASCRS 2024 presentation on toric lens use for patients with low astigmatism
ASCRS 2024: Enrollment begins in Canada for cell therapy trial, targeting corneal endothelial disease
Greg Kunst, CEO of Aurion Biotech, discusses AURN001, a novel cell therapy targeting corneal endothelial disease
ASCRS 2024: Key features of LASIK using an updated laser ablation algorithm for myopia and myopic astigmatism
At ASCRS2024, George O. Waring IV, MD, FACS, provides an overview of his presentation highlighting outcomes for LASIK performed using an updated laser ablation algorithm
Cataract surgery pre-treatment with miLoop: Shorter lensectomy time, less irrigation needed
Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting
ESCRS president Filomena Ribeiro invites ASCRS attendees to 'cataract Olympiad' after successful Refractive Day
Filomena Ribeiro, MD, PhD, FEBO, discusses her presentation on neuroadaptation following the ASCRS Refractive Day
ASCRS 2024: CoFi integrates with CareCredit and marks participation milestone for ophthalmologists and optometrists
Sean Hanlon, CEO of CoFi, details the patient and provider benefits of recent CareCredit integration
ASCRS 2024: New Phase III study results and near-future plans for Neurotech and NT-501
Rich Small, CEO of Neurotech Pharmaceuticals, provides an update on the months ahead for NT-501 encapsulated cell therapy
Carl Zeiss Meditec AG announces completed acquisition of Dutch Ophthalmic Research Center
Zeiss has secured regulatory approvals to acquire DORC and will shift focus to integration implementation
Evaluation of an enhanced monofocal intraocular lens
Three IOLs are evaluated in a randomised study
Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition
Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages
ARxVision, Seeing AI, NaviLens announce partnership for headset programme
The UK's Royal National Institute of Blind People is the global distributor of the headset and ARxVision is partnering with the National Federation of the Blind and Vision Australia to expand global accessibility
Women in ophthalmology series: Ms Neeru A Vallabh gives advice for finding multiple mentors
The glaucoma specialist talks about navigating the world of research, and the realities of motherhood, as a clinician
Increase in the incidence rate of conjunctival melanoma in Australia
Investigators analysed the incidence and mortality rates from conjunctival melanoma cases over a 32-year period
Global partnership targets ROP in premature infants
An AI-supported telemedicine effort from Siloam Vision and Orbis International
Exonate shares results from Phase Ib/IIa trial of EXN407 eye drops for DR and DME
In addition to the primary safety and tolerability endpoints, the study also saw signals of biological response from EXN407
Genetic editing untangles one strand of the AMD web
The opportunities and challenges presented by CRISPR manipulation
Outlook Therapeutics receives positive CHMP opinion for bevacizumab for wet age-related macular degeneration
The European Commission is expected to make a decision about the application before the end of June
An alternative approach to spectacle independence
Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs
How amyloid-beta peptide and tau protein demonstrate degeneration
Proteins common to Alzheimer disease play a significant role in glaucoma
Focusing on functional vision with monofocal lenses
Quantitative and qualitative improvement in IOL design
Assessing long-term impact of ocular injuries after motor vehicle accidents
Researchers investigated patients' ability to drive and work following eye injury
COPHy 2024: Should all elderly patients with acute visual loss go to the emergency department?
A case study emphasises the shifting paradigm in clinical best practices
COPHy 2024: Intraocular inflammation as a risk factor resulting from use of anti-complement agents for GA
Good news for patients: use of anti-complement therapies have caused the growth rate of GA lesions to decrease